Plasmacytoma: all 352 studies

Page 4 of 4. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.

• O6-benzylguanine And Carmustine in Treating Patients With Multiple MyelomaCompletedNCT00004072Phase 2
• 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow DisorderTerminatedNCT00004058Phase 1
• Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After ChemotherapyWithdrawnNCT00004040Phase 2
• Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced CancerStatus unknownNCT00004036Phase 1
• Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003962Phase 1
• Donor Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003960Phase 2
• Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationCompletedNCT00003887Phase 2
• Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or MyelomaStatus unknownNCT00003885Phase 2
• 4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic AmyloidosisCompletedNCT00003853Phase 2
• Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell CountCompletedNCT00003805Phase 3
• Treatment for Chronic Pain in Patients With Advanced CancerCompletedNCT00003687Phase 3
• Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple MyelomaStatus unknownNCT00003603Phase 3
• Epoetin Alfa in Treating Anemia in Patients Who Are Receiving ChemotherapyCompletedNCT00003600Phase 3
• Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic CancersCompletedNCT00003572Phase 2
• Rituximab in Treating Patients With Multiple MyelomaCompletedNCT00003554Phase 2
• Combination Chemotherapy in Treating Patients With Multiple MyelomaCompletedNCT00003493Phase 2
• Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple MyelomaCompletedNCT00003490Phase 2
• Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With CancerCompletedNCT00003408Phase 2
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerCompletedNCT00003406Phase 1/2
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple MyelomaCompletedNCT00003401Phase 2
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple MyelomaCompletedNCT00003399Phase 2
• Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003398Phase 4
• Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003396Phase 2
• Arsenic Trioxide in Treating Patients With Advanced Hematologic CancerCompletedNCT00003395Phase 1
• High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic AmyloidosisCompletedNCT00003353Phase 2
• Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By ChemotherapyCompletedNCT00003341Phase 3
• Combination Chemotherapy in Treating Patients With Advanced CancerCompletedNCT00003331Phase 1
• Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple MyelomaCompletedNCT00003195Phase 2
• Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell CancersStatus unknownNCT00003163Phase 2
• Interleukin-12 in Treating Patients With Multiple MyelomaCompletedNCT00003149Phase 2
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple MyelomaCompletedNCT00003146Phase 2
• High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003116Phase 2
• Interleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsCompletedNCT00003107Phase 1
• Monoclonal Antibody Therapy in Treating Patients With Advanced CancerCompletedNCT00003082Phase 1
• Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight LossCompletedNCT00003077Phase 1/2
• Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple MyelomaCompletedNCT00003007Phase 2
• Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic SyndromeStatus unknownNCT00002989Phase 3
• Decitabine in Treating Patients With Melanoma or Other Advanced CancerCompletedNCT00002980Phase 1
• Bryostatin 1 in Treating Patients With Relapsed Multiple MyelomaCompletedNCT00002907Phase 2
• Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT00002878Phase 3
• High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic MalignanciesCompletedNCT00002818Phase 1
• High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With AmyloidosisCompletedNCT00002810Phase 2
• Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic CancerCompletedNCT00002742Phase 3
• Combination Chemotherapy in Treating Patients With Multiple MyelomaCompletedNCT00002678Phase 3
• SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ TransplantCompletedNCT00002657Phase 2
• Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple MyelomaStatus unknownNCT00002653Phase 3
• Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's DiseaseCompletedNCT00002652Phase 2
• High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First RelapseCompletedNCT00002630Phase 2
• Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With MyelomaStatus unknownNCT00002599Phase 3
• Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple MyelomaCompletedNCT00002552Phase 2
• Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic CancerCompletedNCT00002504Phase 2
• Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic SyndromeCompletedNCT00002502Phase 2

← Plasmacytoma overview